Metraipolis › archive › dc_b4a4dc978692

Targeting Interferon-Gamma (IFN-γ)-Related Signalling Pathways in Inflammatory Bowel Disease: Emerging Inhibitors and Therapeutic Advances — Europe PMC PMID:41164285

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41164285
DOI
10.1155/mi/3181200
License (as archived)
solo-consultazione
Archived
2026-11-09T04:21:49.248Z
SHA-256 of the archived text
0616259d0f2ddde777d1687ab3029d58bf23c89c9c36b9a79c6bbade4f6804db
Stable URL of this page
https://metraipolis.com/documento/dc_b4a4dc978692

How to cite

Targeting Interferon-Gamma (IFN-γ)-Related Signalling Pathways in Inflammatory Bowel Disease: Emerging Inhibitors and Therapeutic Advances — Europe PMC PMID:41164285 — Europe PMC (en), https://europepmc.org/article/MED/41164285 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b4a4dc978692 (Metraipolis archive dc_b4a4dc978692, sha256 0616259d0f2ddde777d1687ab3029d58bf23c89c9c36b9a79c6bbade4f6804db)
BibTeX
@misc{dcb4a4dc978692,
  title = {Targeting Interferon-Gamma (IFN-γ)-Related Signalling Pathways in Inflammatory Bowel Disease: Emerging Inhibitors and Therapeutic Advances — Europe PMC PMID:41164285},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41164285},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b4a4dc978692; sha256 0616259d0f2ddde777d1687ab3029d58bf23c89c9c36b9a79c6bbade4f6804db},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41164285. Agents can read the archived copy with the MCP tool read_document.